Research news

A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.

The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.

A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).

UCLH clinicians have been named in the internationally recognised annual Clarivate listings of the ‘world’s most influential researchers.’

UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.